Protein Therapeutics Market

Table of Content

1. INTRODUCTION
   1. Study Assumptions and Market Definition
   2. Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
   1. Market Overview
   2. Market Drivers
      1. Technological Advancements in Protein Engineering
   3. Market Restraints
      1. High Production Costs and Complex Manufacturing Processes
      2. Stringent Regulatory Requirements and Approval Delays
   4. Market Opportunity
      1. Rising Demand for Targeted Therapies
   5. Market Trends
      1. Growth of Biosimilars in Protein Therapeutics
      2. Advancements in Next-Generation Protein Therapeutics
5. MARKET SEGMENTATION
   1. By Product
      1. Monoclonal Antibodies
      2. Insulin
      3. Fusion Protein
      4. Erythropoietin
      5. Interferon
      6. Human Growth Hormone
      7. Follicle Stimulating Hormone
   2. By Application
      1. Metabolic Disorders
      2. Immunologic Disorders
      3. Haematological Disorders
      4. Cancer
      5. Hormonal Disorders
      6. Genetic Disorders
      7. Others
   3. By Function
      1. Vaccines
      2. Enzymatic
      3. Regulatory
      4. Protein Diagnostics
   4. By End User
      1. Pharmaceutical Companies
      2. Healthcare Service Providers
      3. Research Organizations
      4. Academic Research Institutes
   5. By Key Geographic Regions
      1. North America
         1. United States
         2. Canada
         3. Mexico
      2. Europe
         1. Germany
         2. United Kingdom
         3. France
         4. Italy
         5. Spain
         6. Rest of Europe
      3. Asia Pacific
         1. China
         2. Japan
         3. India
         4. Australia
         5. South Korea
         6. Rest of Asia Pacific
      4. Middle East and Africa
         1. GCC
         2. South Africa
         3. Rest of Middle East and Africa
      5. South America
         1. Brazil
         2. Argentina
         3. Rest of South America
6. COMPETITIVE LANDSCAPE
   1. Company Profile
      1. Abbott.
      2. AbbVie Inc.
      3. Amgen Inc.
      4. AstraZeneca
      5. Biogen Inc.
      6. Bristol-Myers Squibb Company
      7. Boehringer Ingelheim International GmbH.
      8. Baxter.
      9. CSL
      10. Eli Lilly and Company.
      11. F. Hoffmann-La Roche Ltd
      12. Generex Biotechnology Corp.
      13. Genentech, USA Inc.
      14. Johnson & Johnson Services, Inc.
      15. Kyowa Kirin Co., Ltd.
      16. Merck KGaA
      17. Novo Nordisk A/S
      18. Pfizer Inc.
      19. Sanofi
      20. Teva Pharmaceutical Industries Ltd
7. MARKET OPPORTUNITIES AND FUTURE TREND

Frequently Asked Questions

Q.1. What is the projected market value of the global Protein Therapeuticsmarket?

The global market of protein therapeutics is projected to reach USD235.05 Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global Protein Therapeuticsmarket?

The global protein therapeutics market has an estimated annual growth rate of 6.7%.

Q.3. What are the recent trends of Protein Therapeuticsmarket?

Growth of biosimilars in protein therapeutics and advancements in next-generation protein therapeutics are some of the major trends of the market that is projected to boost the market growth in the near future.  

Q.4. Which are the top companies to hold the market share in Protein Therapeutics?

The major companies profiled in this report include Abbott, AbbVie Inc., Amgen Inc., AstraZeneca, Biogen Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Baxter, CSL, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Generex Biotechnology Corp., Genentech, USA Inc, Johnson & Johnson Services, Inc., Kyowa Kirin Co., Ltd., Merck KGaA, Novo Nordisk A/S, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd, among others.   

Q.5. Which is the largest regional market in the Protein Therapeutics?

North America is the largest regional market for Protein Therapeutics.